# Eckert & Ziegler to serve as European contract manufacturer for Telix's Phase III study

Eckert & Ziegler signed a multi-year agreement with Telix Pharmaceuticals to serve as the European contract manufacturing organization for Telix's ProstACT GLOBAL Phase III study, supplying Lu-177 from its Berlin facility.

- Type: Contract
- Announced: 2024-08-13
- Where: Berlin, Germany
- Status: announced
- Products: Lutetium-177, radio-labeled antibody drug conjugate
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eckert & Ziegler](https://endata.com/companies/41023.md) (supplier)
- [Telix Pharmaceuticals Limited](https://endata.com/companies/79144.md) (customer)

## Sources

- [lesechos-comfi.lesechos.fr](https://lesechos-comfi.lesechos.fr/press-release/eckert-ziegler-strahlen-und-medizintechnik-ag-etr-euz-eckert-ziegler-becomes-european-contract-manufacturer-for-telixs-innovative-phase-iii-prostact-global-study-CkDRoUut7VZ), 2024-08-13: "Eckert & Ziegler will serve as the European contract manufacturing organization (CMO) for Telix's ProstACT GLOBAL Phase III study."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.